Effect of pentoxifylline on inflammatory markers in non-diabetic chronic kidney disease patients: A prospective, interventional, open label
World Journal of Nephrology · 25.09.2026 · 15 (3)
DOI: 10.5527/wjn.120037 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Nephrology, online erschienen am 25.09.2026. Verfasst von Ashraf Hassan Abd El Mobdy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Cairo 31511, Egypt. ashrafnephro@med.asu.edu.eg. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND Pentoxifylline (PTX), a methylxanthine derivative, has been shown to exert notable anti-inflammatory and antiproteinuric actions in diabetic kidney disease, contributing to improved sodium handling, attenuation of renal hypertrophy, and reductions in tumour necrosis factor-alpha (TNF-α), interleukin-6 levels, and albuminuria. AIM To determine the impact of PTX on inflammatory biomarkers and the progression of chronic kidney disease (CKD) in non-diabetic patients. METHODS This prospective, interventional, open label, randomized controlled clinical study was conducted on 42 participants aged 18 years or older, of both genders, with CKD stages 3 or 4 and proteinuria < 1 g/24 hours. Participants were placed into two equal groups. Group 1 had standard therapy, including angiotensin-converting enzyme inhibitors (ACEIs; ramipril 1.25 mg), calcium acetate (700 mg), alfacalcidol (0.25 µg), antihypertensives, and diuretics. Group 2 had the same standard therapy plus PTX 400 mg (Trental®) two times per day for six consecutive months. RESULTS There was no significant relationship between TNF-α and high-sensitivity C-reactive protein (hs-CRP) and participants’ gender in both groups. An essential direct correlation was observed between TNF-α and creatinine in both groups. A critical direct correlation was observed between hs-CRP and calcium in group B. There was a significant inverse correlation between the change in TNF-α and estimated glomerular filtration rate, as well as between the change in TNF-α and the urinary protein-to-creatinine ratio. The change in protein creatinine ratio noted in group 2 was mainly due to changes in mean arterial pressure, followed by changes in TNF-α. CONCLUSION In non-diabetic CKD patients, adjunctive treatment with PTX was associated with significant decreases in C-reactive protein levels and proteinuria. The reduction in proteinuria was mainly explained by changes in mean arterial pressure, followed by changes in TNF-α, indicating that hemodynamic factors may play a more prominent role than inflammatory modulation in mediating this effect.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Cairo 31511, Egypt. ashrafnephro@med.asu.edu.eg.
- Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Cairo 31511, Egypt.
- Department of Nephrology, Faculty of Medicine, Ain Shams University Hospital, Cairo 11512, Egypt.
Zitieren
APA
Abd El Mobdy, A. H., Hebah, H. A., Ezzat, M. A., Eid Mohamed, B. A., & Ahmed, F. A. (2026). Effect of pentoxifylline on inflammatory markers in non-diabetic chronic kidney disease patients: A prospective, interventional, open label. World Journal of Nephrology, 15(3). https://doi.org/10.5527/wjn.120037
Vancouver
Abd El Mobdy AH, Hebah HA, Ezzat MA, Eid Mohamed BA, Ahmed FA. Effect of pentoxifylline on inflammatory markers in non-diabetic chronic kidney disease patients: A prospective, interventional, open label. World Journal of Nephrology. 2026;15(3). doi:10.5527/wjn.120037
BibTeX
@article{AbdElMobdy2026,
author = {Abd El Mobdy, Ashraf Hassan and Hebah, Hayam Ahmed and Ezzat, Mohammed Ali and Eid Mohamed, Basant Abdelkarim and Ahmed, Fatma Abdelrahman},
title = {Effect of pentoxifylline on inflammatory markers in non-diabetic chronic kidney disease patients: A prospective, interventional, open label},
journal = {World Journal of Nephrology},
year = {2026},
volume = {15},
number = {3},
doi = {10.5527/wjn.120037}
}
EUVIMED